Symposium on Mucolipin
Function in Disease

Building 60 – The Cloister
National Institutes of Health

Bethesda, Maryland
June 2–3, 2008

Mark your calendar for June 2–3, 2008, and plan to attend the Symposium on Mucolipin Function in Disease at the Cloister (Building 60) on the National Institutes of Health campus in Bethesda, Maryland.

Sponsored by the National Heart, Lung, and Blood Institute (NHLBI) and the National Institute of Neurological Disorders and Stroke (NINDS), this symposium will bring together basic and clinical investigators interested in the cellular function of mucolipins and their implication in Mucolipidosis Type IV and other human diseases. Investigators will share recent research findings and participants will discuss, evaluate, and propose research needs and priorities to further understanding of the disease and develop therapies to treat it.

Confirmed speakers:

• Gideon Bach, M.D., Hadassah Hebrew University (Israel)
• Horacio F. Cantiello, Ph.D., D.V.M., Harvard Medical School/Massachusetts General Hospital
• Ana Maria Cuervo, M.D., Ph.D., Albert Einstein College of Medicine
• Markus Delling, Ph.D., Harvard Medical School
• Hanna (Johnny) Fares, Ph.D., University of Arizona
• Kirill Kiselyov, Ph.D., University of Pittsburgh
• Joseph A. Mindell, M.D., Ph.D., National Institute of Neurological Disorders and Stroke/NIH
• Shmuel Muallem, Ph.D., University of Texas Southwestern Medical Center
• Craig Montell, Ph.D., Johns Hopkins University School of Medicine
• Rosa Puertollano, Ph.D., National Heart, Lung, and Blood Institute/NIH
• Raphael Schiffmann, M.D., Baylor Research Institute
• Susan A. Slaugenhaupt, Ph.D., Harvard Medical School/Massachusetts General Hospital
• Danilo Tagle, Ph.D., National Institute of Neurological Disorders and Stroke/NIH
• Thomas A. Vida, Ph.D., University of Texas – Houston Medical School
• Steven U. Walkley, D.V.M., Ph.D., Albert Einstein College of Medicine
• Ora A. Weisz, Ph.D., University of Pittsburgh
• Haoxing Xu, Ph.D., University of Michigan

Symposium Organizing Committee:

• Rosa Puertollano, Ph.D., Committee Chair, National Heart, Lung, and Blood Institute
• Susan A. Slaugenhaupt, Ph.D., Harvard Medical School/Massachusetts General Hospital
• Kirill Kiselyov, Ph.D., University of Pittsburgh
• Randy Yudenfriend, Mucolipidosis IV Foundation
• Vicki Yudenfriend, Mucolipidosis IV Foundation
• Carol Sadler, National Heart, Lung, and Blood Institute

• Mucolipidosis IV Foundation
• Genpathway, Inc.
• BioMarin Pharmaceutical, Inc.
  

Last updated May 16, 2008